Susquehanna International Group, LLP Embecta Corp. Put Options Transaction History

Susquehanna International Group, LLP

7 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q1 2024 May 07, 2024	BUY	$12.35 - $19.33 $229,710 - $359,537	18,600 Added 184.16%	28,700 $380,000
Q4 2023 Feb 14, 2024	SELL	$12.87 - $19.09 $693,693 - $1.03 Million	-53,900 Reduced 84.22%	10,100 $191,000
Q3 2023 Nov 14, 2023	BUY	$15.0 - $22.17 $816,000 - $1.21 Million	54,400 Added 566.67%	64,000 $963,000
Q2 2023 Aug 11, 2023	SELL	$21.6 - $30.69 $1.31 Million - $1.86 Million	-60,600 Reduced 86.32%	9,600 $207,000
Q1 2023 May 16, 2023	SELL	$23.07 - $32.77 $295,296 - $419,456	-12,800 Reduced 15.42%	70,200 $1.97 Million

Q4 2022 Feb 14, 2023	BUY	$25.29 - $35.48 $1.81 Million - $2.54 Million	71,600 Added 628.07%	83,000 $2.1 Million
Q3 2022 Nov 14, 2022	SELL	$24.0 - $33.42 $33,600 - $46,788	-1,400 Reduced 10.94%	11,400 $328,000

392

52.2M

45.7K

49K

Ticker EMBC
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 57,836,500
Market Cap $723M
Description
Embecta Corp., a medical device company, focuses on the provision of various solutions to enhance the health and wellbeing of people living with diabetes. Its products include pen needles, syringes, and safety devices, as well as digital applications to assist people with managing their diabetes. The company primarily sells its products to whole...

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

Stay updated on Susquehanna International Group, LLP with notifications on news.